As the largest and most advanced pharmaceutical manufacturer of anti-tumor drugs and anti-viral drugs in Laos and one of the fastest-growing large-scale pharmaceutical companies in the region, ElementoPharmas is constructing a series of new production and scientific research facilities that comply with US FDA, UK MHRA, EU GMP and WHO GMP management systems and specifications in strict accordance with the international standards, to meet the huge domestic and global market demands, and it is expected to be completed and put into operation before 2021.